AIDS

Skip Navigation LinksHome > March 27, 2014 - Volume 28 - Issue 6 > Interleukin-6 and D-dimer levels at seroconversion as predic...
AIDS:
doi: 10.1097/QAD.0000000000000155
Clinical Science: Concise Communications

Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression

Hamlyn, Elizabetha,b; Fidler, Saraha; Stöhr, Wolfgangc; Cooper, David A.d; Tambussi, Giuseppee; Schechter, Maurof; Miro, Jose M.g; Mcclure, Myraa; Weber, Jonathana; Babiker, Abdelc; Porter, Kholoudc; for SPARTAC Trial Investigators

Collapse Box

Abstract

Objective: Inflammation and coagulation biomarkers interleukin (IL)-6 and D-dimer are predictive of all-cause mortality in chronic HIV-1 infection; however, their predictive value in individuals with recent infection has not been described.

Methods: SPARTAC was a randomized controlled trial comparing three strategies of intervention in primary HIV-1 infection [no therapy, 12-week or 48-week antiretroviral therapy (ART)]. Plasma IL-6 and D-dimer were measured in 200 participants from sites in Australia, Brazil, UK and Italy. We evaluated age, sex/HIV risk group, time since HIV-1 seroconversion, baseline HIV-RNA, CD4+ cell count and BMI as possible predictors of IL-6 and D-dimer levels at seroconversion using multivariable linear regression. For participants remaining ART-naive, we evaluated whether baseline IL-6 and D-dimer levels independently predicted time to reaching CD4+ cell count less than 350 cells/μl or initiating ART using multivariable Cox proportional hazards models.

Results: Median (interquartile range, IQR) baseline IL-6 and D-dimer levels were 1.45 (0.88–2.41) pg/ml and 0.34 (0.20–0.50) μg/l, respectively. Higher levels were associated with older age (P = 0.008 and 0.004, respectively). Higher D-dimer levels were associated with higher HIV-RNA (P < 0.001). For the 73 participants not initiating ART (median follow-up 225 weeks), of whom 48 reached the primary endpoint, higher baseline IL-6, but not D-dimer, was independently associated with a shorter time to primary endpoint [hazard ratio = 1.38 per additional pg/ml, 95% confidence interval (CI) 1.09–1.75; P = 0.007]. Other baseline predictors were older age (P = 0.030), higher RNA (P = 0.033) and lower CD4+ cell count (P < 0.001).

Conclusion: IL-6 levels at time of HIV-1 seroconversion independently predict HIV-1 disease progression in patients with primary HIV-1 infection.

© 2014 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.